Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2025 11:00 ET | Source: BVI Medical, Inc.

BVI Medical Announces Approval of Breakthrough Technology: FDA 510(k) Clearance of its Laser Endoscopy Ophthalmic System: Leos™

BVI Medical, announced that it has received 510(k) clearance from the U.S. FDA for its innovative glaucoma surgical system, Leos™
April 08, 2025 04:52 ET | Source: Research and Markets

Ophthalmology Market Report 2025 | Industry to Reach US$93.7 Billion by 2030 | Emerging Research Activities of Ophthalmology Treatments and Availability of Grants Present Business Opportunities

Dublin, April 08, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses &...
March 27, 2025 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- SpyGlass Pharma™, a...
March 17, 2025 11:02 ET | Source: Glaucoma Research Foundation (GRF)

New Research Reveals One Million More Glaucoma Cases Than Previously Believed — Glaucoma Research Foundation Urges Early Screening

SAN FRANCISCO, March 17, 2025 (GLOBE NEWSWIRE) -- The Glaucoma Research Foundation (GRF) is launching a national awareness campaign, “Your Eyes Say Thanks,” to educate the public on the importance...
February 19, 2025 09:00 ET | Source: The Eye Health Summit

Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts

The Eye Health Summit, a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event.
February 04, 2025 08:00 ET | Source: Iantrek, Inc.

Iantrek Appoints Adam Szaronos as Chief Executive Officer

WHITE PLAINS, N.Y., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a medical technology company pioneering bio-interventional approaches for chronic eye diseases, today announced the appointment...
January 17, 2025 06:23 ET | Source: Research and Markets

$6.8 Bn Glaucoma 68-Market Analysis and Sales Forecasts 2023-2033 Featuring Abbvie, Allergan, Alcon, Pfizer, Merck, Santen, Ocular Therapeutix, pH Pharma, Nicox, DWTI, Thea Pharma, Betaliq, and Tarsier Pharma

Dublin, Jan. 17, 2025 (GLOBE NEWSWIRE) -- The "Glaucoma: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.This report covers the 68 geographical...
January 13, 2025 08:00 ET | Source: Iantrek, Inc.

Iantrek Announces First Commercial Cases of its C.Rex Micro-Interventional System for Trabecular Outflow Enhancement

White Plains, NY., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc, a venture-backed, medical technology company pioneering next-generation bio- and micro-interventional technologies for the...
December 10, 2024 08:00 ET | Source: Iantrek, Inc.

Iantrek Announces Peer-Reviewed Publication Highlighting 12-Month Safety and Effectiveness Results for its Bio-Interventional Uveoscleral Outflow Technology in Open-Angle Glaucoma Patients

White Plains, Dec. 10, 2024 (GLOBE NEWSWIRE) -- White Plains, NY – December 10, 2024 – Iantrek, Inc., a venture-backed, medical technology company pioneering next-generation bio- and...
December 09, 2024 11:03 ET | Source: Research and Markets

Glaucoma Therapeutics Strategic Industry Report 2024 - Growth in Specialty Eye Clinics Enhancing Treatment Reach

Dublin, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The "Glaucoma Therapeutics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Glaucoma...

Next Page keyboard_arrow_right